Early remdesivir treatment was associated with lower graft loss and cardiovascular events in kidney transplant recipients, noted Nitipong Permpalung, MD, MPH.
Young adults with sarcoma face challenges that extend well beyond treatment, and closing gaps in research funding and specialty care could improve outcomes for this population and beyond, according to ...
Navista names Jeff Hunnicutt COO, bringing in a well-known oncology leader with experience in technology and innovation at ...
Moving to a subQ formulation makes sense, if you want to be 100% convenient for patients and the centers that treat them, explains Xavier Leleu, MD, PhD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results